dapagliflozin
astrazeneca
['astrazeneca']
late-breaking data: detailed results from our deliver phase iii trial for #heartfailure patients with mildly reduced or preserved ejection fraction were presented today at #esccongress and published in . learn more: 
The official Twitter feed for AstraZeneca US. For more info visit http://t.co/5VlUaVGyiC.